End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
435.8 INR | +0.43% | -6.50% | -20.93% |
May. 10 | NetScientific says PDS Biotech's Versamune meets endpoints | AN |
May. 10 | PDS Biotechnology Says Head, Neck Cancer Therapy Met Main Goal in Mid-Stage Study | MT |
Sales 2024 * | 105B 1.25B | Sales 2025 * | 123B 1.47B | Capitalization | 58.02B 695M |
---|---|---|---|---|---|
Net income 2024 * | 2.16B 25.83M | Net income 2025 * | 3.18B 38.03M | EV / Sales 2024 * | 0.56 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.47 x |
P/E ratio 2024 * |
26.8
x | P/E ratio 2025 * |
18.2
x | Employees | 180 |
Yield 2024 * |
0.36% | Yield 2025 * |
1.39% | Free-Float | 21.74% |
Latest transcript on PDS Limited
1 day | +0.43% | ||
1 week | -6.50% | ||
Current month | -6.24% | ||
1 month | -7.33% | ||
3 months | -19.05% | ||
6 months | -25.54% | ||
Current year | -20.93% |
Managers | Title | Age | Since |
---|---|---|---|
Sanjay Jain
CEO | Chief Executive Officer | - | 21-01-14 |
Sunvinder Singh
PSD | President | 30 | 18-10-02 |
Rahul Ahuja
DFI | Director of Finance/CFO | 52 | 23-01-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 72 | 11-04-05 | |
Payel Seth
BRD | Director/Board Member | 66 | 11-04-05 |
Pallak Seth
BRD | Director/Board Member | 46 | 11-04-05 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 439.4 | +0.81% | 23,518 |
24-05-09 | 435.8 | +0.43% | 33,785 |
24-05-08 | 434 | -0.82% | 28,506 |
24-05-07 | 437.6 | +0.95% | 48,388 |
24-05-06 | 433.5 | -1.62% | 63,447 |
End-of-day quote NSE India S.E., May 08, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.93% | 695M | |
+7.47% | 424B | |
+4.59% | 144B | |
-30.97% | 44.44B | |
+13.90% | 18.47B | |
+15.92% | 10.69B | |
+36.76% | 9B | |
+6.70% | 7.23B | |
-6.64% | 6.58B | |
+30.48% | 6.39B |
- Stock Market
- Equities
- PDSL Stock